
Pritelivir healed all HSV lesions by day 28 in 63% of immunocompromised adults vs 34% with comparators.
ObGyn.net is looking for US-based MDs to share their thoughts on new clinical developments, practice management issues, patient conundrums, regulatory headaches, and more.
ObGyn.net is looking for US-based MDs to share their thoughts on new clinical developments, practice management issues, patient conundrums, regulatory headaches, and more. The content should be directed at physicians, and should have a perspective; we want more than just a rehashing of clinical research, we want you to share your experiences and opinions!
Bloggers are paid, and can contribute weekly, biweekly or monthly. Posts should be between 300-600 words.
Interested? Email us at





